Cardlytics Q4 2023 Adj EPS $0.14 Beats $0.12 Estimate, Sales $89.167M Miss $89.551M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cardlytics reported Q4 2023 adjusted EPS of $0.14, surpassing the $0.12 estimate, marking a 148.28% increase from last year's losses. However, their sales of $89.167M fell short of the $89.551M estimate, despite being an 8.08% increase from the previous year.
March 14, 2024 | 8:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardlytics surpassed EPS estimates but missed on sales for Q4 2023, showing significant YOY growth.
The positive earnings surprise and significant year-over-year growth in EPS are likely to be viewed favorably by investors, potentially leading to a short-term increase in stock price. However, the slight miss on sales estimates could temper some of the positive momentum.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100